IP Verse

Crispr-Based Genome Modification And Regulation

Patent No. EP3138912 (titled "Crispr-Based Genome Modification And Regulation") was filed by Sigma Aldrich on Dec 5, 2013. The application was issued on Dec 5, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
POHLMANSep 5, 2019POHLMAN
BASFSep 4, 2019EISENFUHR SPEISER
BAYER BAYERJun 18, 2019COHAUSZ & FLORACK
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBFeb 22, 2019VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
GRUNDJan 30, 2019GRUND
SCHLICHDec 6, 2018SCHLICH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3138912

SIGMA ALDRICH
Application Number
EP16183725A
Filing Date
Dec 5, 2013
Status
Revoked
Aug 26, 2022
Publication Date
Dec 5, 2018
External Links
Slate, Register , Google Patents